NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$4.96 and traded as low as C$4.74. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.86, with a volume of 1,372,449 shares traded.
Analyst Ratings Changes
Separately, BMO Capital Markets dropped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.25 in a research report on Tuesday, November 19th.
View Our Latest Analysis on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Stock Performance
The stock's fifty day moving average is C$4.59 and its two-hundred day moving average is C$4.96. The firm has a market capitalization of C$1.22 billion, a price-to-earnings ratio of -3.12, a price-to-earnings-growth ratio of 0.74 and a beta of 1.05. The company has a debt-to-equity ratio of 129.42, a quick ratio of 0.06 and a current ratio of 0.25.
NorthWest Health Prop Real Est Inv Trust Company Profile
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Featured Stories
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.